Monopar Therapeutics
MNPR
#7537
Rank
โ‚ฌ0.42 B
Marketcap
62,90ย โ‚ฌ
Share price
-1.84%
Change (1 day)
-20.88%
Change (1 year)

Earnings for Monopar Therapeutics (MNPR)

Earnings in 2026 (TTM): -โ‚ฌ15.38 Million

According to Monopar Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ12.51 Million, an increase over its 2024 earnings that were of -โ‚ฌ14.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monopar Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ15.38 Million22.96%
2025 -โ‚ฌ12.51 Million-11.99%
2024 -โ‚ฌ14.21 Million85.5%
2023 -โ‚ฌ7.66 Million-20.1%
2022 -โ‚ฌ9.59 Million15.52%
2021 -โ‚ฌ8.3 Million44.39%
2020 -โ‚ฌ5.75 Million49.23%
2019 -โ‚ฌ3.86 Million28.04%
2018 -โ‚ฌ3.01 Million-80.07%
2017 -โ‚ฌ15.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.15 Billion 774.98%๐Ÿ‡บ๐Ÿ‡ธ USA